NaCl (placebo)
NaCl (placebo) is a pharmaceutical drug with 6 clinical trials. Historical success rate of 66.7%.
Success Metrics
Based on 2 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
2
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
66.7%
2 of 3 finished
33.3%
1 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Efficacy and Safety of Coenzyme I for Injection on Vascular Aging.
The Impact of Local Anesthetic Dilution on Possible Blinding for Nerve Blocks
Effect of YAP1-inhibition in Surgical Wounds.
Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.
Clinical Trials (6)
Efficacy and Safety of Coenzyme I for Injection on Vascular Aging.
The Impact of Local Anesthetic Dilution on Possible Blinding for Nerve Blocks
Effect of YAP1-inhibition in Surgical Wounds.
Study Evaluating Denosumab on Bone and Vascular Metabolism in Osteoporotic Chronic Kidney Disease
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.
Botulinum Toxin Treatment in Craniofacial, Inguinal, Palmar, Plantar and Truncal Hyperhidrosis
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6